Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis.
about
The extracellular matrix Component Psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilmsMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaPseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice.Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosisAzithromycin increases survival and reduces lung inflammation in cystic fibrosis miceImmunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) miceA commensal streptococcus hijacks a Pseudomonas aeruginosa exopolysaccharide to promote biofilm formation.Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy.The sigma factor AlgU (AlgT) controls exopolysaccharide production and tolerance towards desiccation and osmotic stress in the biocontrol agent Pseudomonas fluorescens CHA0.Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms.Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response.Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.Distribution, organization, and ecology of bacteria in chronic woundsCloning of alginate lyase gene (alxM) and expression in Escherichia coli.
P2860
Q28535199-8406D03C-9374-4FCE-A045-C6ECA956D3CCQ29615286-3A13493B-7961-4887-A7DD-8E2F54491B1AQ30434925-168FC6DA-C15A-4272-9253-C6CBE2E4699DQ33713275-531A21DF-E038-4C5B-A103-F3C2BB5360F6Q33769205-5B975D4A-213C-4833-A5D1-A94AF468B9EBQ34185975-661989DF-4595-4C0B-8781-399F5A257D2DQ34532344-15879EAA-A72F-4D15-B19E-79F9124F70D4Q36095028-3CD602E0-F046-413E-9800-D5188334B89DQ36356762-B7ED7950-7C1A-4E2B-9606-95C943F02510Q36505398-A88FB2EC-9AE3-49CB-9841-3CBB0AF56026Q39493548-2A75B7AD-759B-4BC4-A04E-DB1FE14C880DQ40149473-A18FD7CD-C1DC-4981-895B-540303DA1799Q40155064-7148BC09-D4D3-4D78-8DA4-95B818EF4780Q40200920-D3C0266B-07DB-410D-A8E2-5ED80E0C831BQ40428701-788CCE15-0B6B-4432-A41D-6EEE894715ECQ41144869-06D167FF-E4CB-4210-835A-1EFDA15A01D1Q42406600-75BAFF90-D5F3-485B-BB7A-FFA7AD41FEB6Q42926325-BC135E34-CEF3-464A-AAEE-02EADE9B383D
P2860
Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Purification, characterization ...... patients with cystic fibrosis.
@en
type
label
Purification, characterization ...... patients with cystic fibrosis.
@en
prefLabel
Purification, characterization ...... patients with cystic fibrosis.
@en
P2093
P2860
P1476
Purification, characterization ...... patients with cystic fibrosis.
@en
P2093
P2860
P304
P407
P577
1989-04-01T00:00:00Z